2021 Best Editor Award
The Journal of Molecular Cell Biology (JMCB) is fortunate to have a team of talented and dedicated ad hoc editors who offer their time and expertise to JMCB-related scientific communicating and publishing activities. The JMCB 2021 Best Editor Award recognizes Early-Career Guest Editors who truly stand out for providing consistently exemplary work and significant contributions to JMCB in the Year 2021.
We are delighted to announce that the two recipients of the JMCB 2021 Best Editor Award are Prof. Xing Liu from the University of Science and Technology of China and Prof. Xiang Zhou from Fudan University. We are highly appreciate of their professionalism and dedication to JMCB.
Dr. Xing Liu
Dr. Xing Liu is a professor working at the University of Science and Technology of China (USTC). She graduated, with a PhD in Molecular & Cell Biology, from USTC in 2014. After a postdoctoral fellowship in chemical biology, she joined the Anhui Key Laboratory for Chemical Biology and Cellular Dynamics as a tenured associate professorship in 2017. She set up her independent research program in Ministry of Education (MOE) Key Laboratory for Membraneless Organelles and Cellular Dynamics in 2019. In the same year, she received the National Natural Science Foundation of China (NSFC) Excellent Young Scientist Award (2019). The research interest in Dr. Liu's laboratory is to understand the organelle dynamics and plasticity control underlying cell fate decision in mitosis. The active research areas in her research program include correlative light-electron microscopic imaging and chemical biology of mitosis in 3D organoids.
Visit her lab's website here.
Dr. Xiang Zhou
Dr. Xiang Zhou earned his PhD in Genetics from Wuhan University in China, and completed his postdoctoral training at the Indiana University School of Medicine and Tulane University School of Medicine in the USA. He is currently an Associate Professor at the Shanghai Cancer Center and Institutes of Biomedical Sciences of Fudan University. His research interests focus on several important questions in cancer. What are the mechanisms underlying functions of p53 or mutant p53 in cancer? How do we translate knowledge about p53 signaling into clinical practice? How to develop new therapeutic methods by targeting "undruggable" molecules? By addressing these questions, he has published over 50 articles in Proc. Natl Acad. Sci. USA, Mol. Cancer, Cancer Res., Cell Death Differ., eLife, J. Mol. Cell Biol., etc.
Visit his lab's website here.
Interested in becoming an Early-Career Guest Editor?
JMCB is recruiting Early-Career Guest Editors. To find out more, please visit: https://dbpia.nl.go.kr/jmcb/pages/jmcb-early-career-guest-editors-recruited.
